Nutrition and thrombogenic factors

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 4 PART 1 SUPPL., 1999, Pages 16-20

  Di Minno, G ^a   Piemontino, U ^b   Cerbone, A M ^b  

^a Cattedra di Gerontologia e Geriatria   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Diet; Nutrition; Recurrent myocardial infarction; Thrombogenic factors

Indexed keywords

ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; BLOOD; DIETARY FIBER; FAT INTAKE; FISH; HUMAN; NUTRITION; REVIEW; THROMBOSIS;

ANIMALS; CHOLESTEROL, LDL; DIETARY FATS; DIETARY FIBER; EICOSAPENTAENOIC ACID; FISHES; HUMANS; NUTRITION PHYSIOLOGY; THROMBOSIS;

EID: 0033169978     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Leren P (1970) The Oslo Diet-Heart Study. Eleven-year report. Circulation 42: 39-46
2. Morris JN, Ball KP, Antonis A, Brigden WW, Burns-Cox CJ, Fulton M, Haigh M, Hall GJL, Hanington E, Heady JA, McAllen PM, Pilkington TRE, Royston GR, Sharland DE, Sowry GSC, Wilson C (1968) Controlled trial of soya-bean oil in myocardial infarction. Lancet II: 694-700
3. Woodhill JM, Palmer AJ, Leelarthaepin B, McGilchrist C, Blacket RB (1978) Low fat, low cholesterol in secondary prevention of coronary heart disease. Adv Exp Med Biol 209: 317-331
4. Research Committee (1965) Low-fat diet in myocardial infarction: a controlled trial. Lancet II: 501-504
5. Rose GA, Thompson WB, Williams RT (1965) Corn oil in treatment of ischemic heart disease. Br Med J 1: 1531-1533
6. Kromhout D, Bosschieter EB, Coulander CL (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312: 1205-1209
7. Shekelle RB, Missell LV, Oglesby P, Shryock AM, Stamler J (1985) Fish consumption and mortality from coronary heart disease. Br Med J 313: 820
8. Norell SE, Ahloom A Feychting M, Pedersen NL (1986) Fish consumption and mortality from coronary heart disease. Br Med J 293: 426
9. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet II: 117-119
10. Burr ML, Gilbert JF, Holliday RM, Elwood PC, Fenily AM, Rogers S, Sweetnam PM, Deadman NM (1989) Effects of changes in fat, fish, and fiber intakes on death and myocardial infarction: diet and myocardial infarction (DART). Lancet II: 757-761
11. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J (1994) Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 343: 1454-1459
12. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ (1994) A prospective study of plasma homocysteine and risk of ischemic stroke. Stroke 25: 1924-1930
13. Fermo I, Viganò D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A (1995) Prevalence of moderate homocyst(e)inemia in patients with early-onset venous and arterial occlusive disease. Ann Inern Med 123: 747-753
14. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274: 1049-1057
15. Malinow MR (1996) Plasma homocyst(e)ine: a risk factor for arterial occlusive disease. J Nutr 126: 1238-1243
16. Graham JM, Daly LE, Refsum HM, Robinson K, Brattstörm LE, Ueland PM, Palma-Reis J, Boers GHJ, Sheahan RG, Israelsson B, Viterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht W, de Valk HW, Sales Lúis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Medrano MJ, Candito M (1997) Plasma homocysteine as a risk factor for vascular disease. JAMA 277: 1775-1781
17. Ueland PM, Mansoor MA, Guttormsen AB, Muller F, Aukrust P, Refsum H, Svardal AM (1996) Reduced, oxidized and protein-boundforms of homocysteine and other aminothiols in plasma comprise the redox thiol status - A possible element of the extracellular antioxidant defense system. J Nutr 126: 1281S-1284S
18. Di Minno G, Davì G, Margaglione M, Cirillo F, Grandone E, Ciabattoni G, Catalano I, Strisciuglio P, Andria G, Patrono C, Mancini M (1993) Abnormally high thromboxane A2 biosynthesis in homozigous homocystinuria. Evidence for platelet involvment and probucol-sensitive mechanisms. J Clin Invest 90: 1400-1406
19. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dermandy JA (1987) Leukocytes and the risk of ischemic disease. JAMA 257: 2318-2324
20. Di Minno G, Grandone E, Margaglione M (1997) Clinical relevance of polymorphic markers of arterial thrombosis. Thromb Haemostas 78: 462-466
21. Danesh J, Collins R, Appleby P , Peto R (1998) Association of fibrinogen, c-reactive protein, albumin, or leukocyte count with coronary heart disease. meta-analyses of prospective studies. JAMA 279: 1477-1482
22. Trevisan M, Krogh V, Freudenehim J, Blake A, Muti P, Panico S, Farinaro E, Mancini M, Menotti A, Ricci G and the Research Group ATS-RF2 of the Italian National Research Council (1990) Consumption of olive oil, butter, and vegetable oils and coronary heart disease risk factors. JAMA 263: 688-692
23. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willet WC (1996) Vegetable, fruit and cereal fiber intake and risk of coronary heart disease among men. JAMA 275: 447-451
24. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanj AN (1997) A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 336: 1117-1124
25. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbles FJM, Blom HJ (1995) Thermolable 5,10-methylenetetrahydrofolatereductase as a cause of mild hyperhomocystinemia. Am J Hum Genet 56: 142-150
26. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Hevvel LP, Roen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113
27. Kluijtmans LA, van den Hevuel LPWJ, Boers GHJ, Frosst P, Stevens EM, van Oost BA, den Heijer M, Trijbels FS, Rozen R, Blom HJ (1996) Molecular genetic analysis in mild HHcy: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58: 35-41
28. Wicken DEL, Wang XL, Sim AS, McCredie M (1996) Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase C677T mutation. Arterioscler Thromb Vasc Biol 16: 878-882
29. de Franchis R, Mancini FP, D'Angelo A, Sebastio G, Fermo I, De Stefano V, Margaglione M, Mazzola G, Di Minno G, Andria G (1996) Elevated total plasma homocysteine and 677C->T mutation of the 5,10 methylenetetrahydrofolate reductase gene in thrombotic vascular disease. Am J Hum Genet 59: 262-264
30. Sacchi E, Tagliabue L, Duca F, Mannucci PM (1977) High frequency of C677T mutation in the methylenetetrahydrofolate (MTHFR) reductase in northern Italy. Thromb Haemostas 78: 963-964
31. Arruda VR, von Zuben PM, Chiaparini LC, Annichino-Bizzacchi JM, Costa FF (1977) The mutation Ala677->Val in the methylenetetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemostas 77: 818-821
32. Margaglione M, D'Andrea G, d'Addedda M, Giuliani N, Cappucci G, Iannacone L, Vecchione G, Grandone E, Brancaccio V, Di Minno G (1998) The methylenetetrahydrofolate reductase TTT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemostas 79: 907-911
33. Gallagher PM, Meleady R, Shields DC, Tank S, McMaster D, Rozen R, Evans A, Graham JM, Whitehead AS (1996) Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation. Circulation. 94: 2154-2158
34. Ma J, Stampfer MJ, Hennekens C, Frosst P, Selhub J, Horsford J, Malinow R, Willett WC, Rozen R (1996) Methilenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine and risk of myocardial infarction in US physicians. Circulation 94: 2410-2416
35. Schmitz C, Lindpainter K, Verhoef P, Graziano JM, Buring J (1996) Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case control study. Circulation 94: 1812-1814
36. Schwartz SM, Siscovick DS, Malinow MR, Rosendal FR, Beverly K, Hess DJ, Psaty EM, Longsreth WT, Koepsell TD, Raughunathan TE, Reitsma PH (1997) Myocardial infarction in young women in relation to plasma total homocysteine, folate and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 96: 412-417
37. Van Bochxmeer FM, Mamotte CDS, Vasikaran SD, Taylor RR (1997) Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation 95: 21-23
38. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampfer MJ (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279: 359-364
39. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, Gluckman RA, Block PC, Upson B (1998) Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 338: 1009-1015
40. Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J (1995) Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346: 85-89
41. den Heijer M, Brouwer IA, Bos GMJ (1998) Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vase Biol 18: 356-361
42. Di Minno G, Mancini FP, and Margaglione M (1996) Hemostatic variables and ischemic cardiovascular disease: do we need a concerted effort for more profitable future clinical investigation? Cardiovasc Drugs Ther 10: 743-749
43. Gensini GF, Micheli S, Prisco D, Abbate R (1996) Menopause and risk of cardiovascular disease. Thromb Res 84: 1-29